BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tran C, Heng B, Teo JD, Humphrey SJ, Qi Y, Couttas TA, Stefen H, Brettle M, Fath T, Guillemin GJ, Don AS. Sphingosine 1-phosphate but not Fingolimod protects neurons against excitotoxic cell death by inducing neurotrophic gene expression in astrocytes. J Neurochem 2020;153:173-88. [PMID: 31742704 DOI: 10.1111/jnc.14917] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Skoug C, Martinsson I, Gouras GK, Meissner A, Duarte JMN. Sphingosine 1-Phoshpate Receptors are Located in Synapses and Control Spontaneous Activity of Mouse Neurons in Culture. Neurochem Res 2022. [PMID: 35781853 DOI: 10.1007/s11064-022-03664-3] [Reference Citation Analysis]
2 Gutner UA, Shupik MA. The Role of Sphingosine-1-Phosphate in Neurodegenerative Diseases. Russ J Bioorg Chem 2021;47:1155-71. [DOI: 10.1134/s1068162021050277] [Reference Citation Analysis]
3 Jiang H, Joshi S, Liu H, Mansor S, Qiu L, Zhao H, Whitehead T, Gropler RJ, Wu GF, Cross AH, Benzinger TLS, Shoghi KI, Perlmutter JS, Tu Z. In Vitro and In Vivo Investigation of S1PR1 Expression in the Central Nervous System Using [3H]CS1P1 and [11C]CS1P1. ACS Chem Neurosci 2021;12:3733-44. [PMID: 34516079 DOI: 10.1021/acschemneuro.1c00492] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
4 Peruzzotti-Jametti L, Willis CM, Hamel R, Krzak G, Pluchino S. Metabolic Control of Smoldering Neuroinflammation. Front Immunol 2021;12:705920. [PMID: 34249016 DOI: 10.3389/fimmu.2021.705920] [Reference Citation Analysis]
5 Cao J, Xian W, Palihati M, Zhu Y, Wang G, Xie Y, Zhou G, You L. Deficiency of intellectual disability-related gene Brpf1 reduced inhibitory neurotransmission in MGE-derived GABAergic interneurons. G3 (Bethesda) 2021:jkab090. [PMID: 33744924 DOI: 10.1093/g3journal/jkab090] [Reference Citation Analysis]
6 Qi Y, Wang W, Song Z, Aji G, Liu XT, Xia P. Role of Sphingosine Kinase in Type 2 Diabetes Mellitus. Front Endocrinol (Lausanne) 2020;11:627076. [PMID: 33633691 DOI: 10.3389/fendo.2020.627076] [Reference Citation Analysis]
7 Nematullah M, Hoda MN, Nimker S, Khan F. Restoration of PP2A levels in inflamed microglial cells: Important for neuroprotective M2 microglial viability. Toxicol Appl Pharmacol 2020;409:115294. [PMID: 33069748 DOI: 10.1016/j.taap.2020.115294] [Reference Citation Analysis]
8 Chua XY, Ho LTY, Xiang P, Chew WS, Lam BWS, Chen CP, Ong WY, Lai MKP, Herr DR. Preclinical and Clinical Evidence for the Involvement of Sphingosine 1-Phosphate Signaling in the Pathophysiology of Vascular Cognitive Impairment. Neuromolecular Med 2021;23:47-67. [PMID: 33180310 DOI: 10.1007/s12017-020-08632-0] [Reference Citation Analysis]
9 Guo Y, Gan X, Zhou H, Zhou H, Pu S, Long X, Ren C, Feng T, Tang H. Fingolimod suppressed the chronic unpredictable mild stress-induced depressive-like behaviors via affecting microglial and NLRP3 inflammasome activation. Life Sci 2020;263:118582. [PMID: 33058911 DOI: 10.1016/j.lfs.2020.118582] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
10 Linnerbauer M, Rothhammer V. Protective Functions of Reactive Astrocytes Following Central Nervous System Insult. Front Immunol 2020;11:573256. [PMID: 33117368 DOI: 10.3389/fimmu.2020.573256] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
11 Zeng Z, Roussakis AA, Lao-Kaim NP, Piccini P. Astrocytes in Parkinson's disease: from preclinical assays to in vivo imaging and therapeutic probes. Neurobiol Aging 2020;95:264-70. [PMID: 32905922 DOI: 10.1016/j.neurobiolaging.2020.07.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Cohan S, Lucassen E, Smoot K, Brink J, Chen C. Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article. Biomedicines 2020;8:E227. [PMID: 32708516 DOI: 10.3390/biomedicines8070227] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
13 Langeslag M, Kress M. The ceramide-S1P pathway as a druggable target to alleviate peripheral neuropathic pain. Expert Opin Ther Targets 2020;24:869-84. [PMID: 32589067 DOI: 10.1080/14728222.2020.1787989] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Sudhadevi T, Ha AW, Ebenezer DL, Fu P, Putherickal V, Natarajan V, Harijith A. Advancements in understanding the role of lysophospholipids and their receptors in lung disorders including bronchopulmonary dysplasia. Biochim Biophys Acta Mol Cell Biol Lipids 2020;1865:158685. [PMID: 32169655 DOI: 10.1016/j.bbalip.2020.158685] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Wang W, Xiang P, Chew WS, Torta F, Bandla A, Lopez V, Seow WL, Lam BWS, Chang JK, Wong P, Chayaburakul K, Ong WY, Wenk MR, Sundar R, Herr DR. Activation of sphingosine 1-phosphate receptor 2 attenuates chemotherapy-induced neuropathy. J Biol Chem 2020;295:1143-52. [PMID: 31882542 DOI: 10.1074/jbc.RA119.011699] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]